Literature DB >> 31332021

TCR Gene Therapy Improves AML Prognosis.

.   

Abstract

T cells engineered to express a receptor specific for Wilms tumor antigen 1 helped prevent relapse in a small trial of patients with acute myeloid leukemia who had received an allogeneic stem-cell transplant. ©2019 American Association for Cancer Research.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31332021     DOI： 10.1158/2159-8290.CD-NB2019-083

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


  1 in total

1.  Higher Expression of WT1 With Lower CD58 Expression may be Biomarkers for Risk Stratification of Patients With Cytogenetically Normal Acute Myeloid Leukemia.

Authors:  Cunte Chen; Zhuowen Chen; Chi Leong Chio; Ying Zhao; Yongsheng Li; Zhipeng Liu; Zhenyi Jin; Xiuli Wu; Wei Wei; Qi Zhao; Yangqiu Li
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.